Suicide risk and antipsychotic side effects in schizophrenia: nested case–control study

ConclusionsA lower suicide risk identified among patients with EPS could potentially reflect higher antipsychotic adherence, exposure to higher dosage, or polypharmacy among these patients. Copyright © 2016 John Wiley & Sons, Ltd.

Source: Human Psychopharmacology: Clinical and Experimental - February 29, 2016 Category: Psychiatry Authors: Johan Reutfors, Eric Clapham, Shahram Bahmanyar, Lena Brandt, Erik G. Jönsson, Anders Ekbom, Robert Bodén, Urban Ösby Tags: Short Communication Source Type: research